APA (7th ed.) Citation

Rao, A. K., Minhaj, F. S., Carter, R. J., Duffy, J., Satheshkumar, P. S., Delaney, K. P., . . . Cohn, A. C. (2025). Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023. MMWR: Morbidity & Mortality Weekly Report, 74(25), 385. https://doi.org/10.15585/mmwr.mm7422a3

Chicago Style (17th ed.) Citation

Rao, Agam K., et al. "Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023." MMWR: Morbidity & Mortality Weekly Report 74, no. 25 (2025): 385. https://doi.org/10.15585/mmwr.mm7422a3.

MLA (9th ed.) Citation

Rao, Agam K., et al. "Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023." MMWR: Morbidity & Mortality Weekly Report, vol. 74, no. 25, 2025, p. 385, https://doi.org/10.15585/mmwr.mm7422a3.